Delivery Order SPE2DB20D3104-SPE2DB23FV4X6
Award Date 1/25/23
Potential Completion Date 1/26/23
Potential Value $63K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order valued at $3,494.92 for the supply of GARDASIL 9 SYRINGE 0.5ML. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside. The contract has an Ultimate Completion Date of July 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,276.02 firm fixed price delivery order is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of February 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of GARDASIL 9 syringes (0.5 mL). The firm-fixed-price delivery order, valued at $14,653.72, has a completion date of November 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a $12,548 delivery order contract to AmerisourceBergen Drug Corp for the supply of GARDASIL 9 pharmaceutical syringes. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has a firm...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of GARDASIL 9 syringes (0.5mL) to the Defense Logistics Agency (DLA). The $5,355.70 firm fixed-price delivery order contract has a completion date of January 29, 2025. The contract is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of GARDASIL 9 SYRINGE 0.5ML. The award, valued at $2,603.30, is a Firm Fixed Price Delivery Order with an ultimate completion date of April 8, 2025. This contract represents an order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $7,141.46 Delivery Order from the Defense Logistics Agency (DLA) for GARDASIL 9 syringes. The contract has an ultimate completion date of November 29, 2024 and is a Firm Fixed Price agreement. This award is under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,158.00, is for the delivery of GARDASIL 9 vaccine syringes. It is a firm fixed-price delivery order contract with an ultimate completion date of January 23, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,222.17, is for the delivery of GARDASIL 9 syringes. It is a firm fixed-price delivery order contract with a period of performance through March 6, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $15,075.49 for the supply of GARDASIL 9 SYRINGE 0.5ML. The contract, which is a firm fixed price arrangement, was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of July 11, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery Contract (IDC) with...